DCI Research

Sophia Smith PhD, MSW, presents "Evolution of the Cancer Distress Coach app to manage PTSD symptoms in cancer survivors" Dec 9 at noon.

You can count on one hand the number of times a young graduate student finds a drug, then the drug is patented, licensed, and in a phase 2 trial within a couple years.

Who should get screened and what happens if something is found ?

Siqi Li was one of six senior PhD students in the School of Medicine were awarded the Chancellor’s Award for Research Excellence in basic science research. 

Brent Hanks, MD, PhD, was named associate director of Translational Science for the Melanoma Disease Group this month.

Angelo Moore, PhD, MSN, RN, NE-BC, retired from the Army in 2015, but his service to his countrymen continues. In civilian life, he serves the historically underserved.

An injectable drug used to reduce stubbornly high cholesterol levels appears in animal studies to also enhance the immune response of immune checkpoint inhibitors.

The American Cancer Society has a long history of awarding grants to DCI researchers as they work to better understand the complexities of cancer and develop new treatments.

Daniel Sullivan, MD, professor emeritus in the Duke University Department of Radiology, received an award from the Prevent Cancer Foundation, on Oct. 28.

SHIELD-RT is, broadly across medicine, “one of the first randomized interventional studies to see if machine learning can improve patient outcomes."

NCI welcomes the Duke BioRepository & Precision Pathology Center as the new site of the Southern Division of the Cooperative Human Tissue Network.

Researchers in the Netherlands reported last week on their discovery of a set of previously unidentified head & neck organs. Yvonne Mowery, MD, PhD, weighs in.

One top trainee from each of the eight DCI Research Programs presented their pioneering cancer research projects. Benjamin Mayro received the Bell Award.

Komen scholar Donald McDonnell, PhD, spoke about the importance of investing in breast cancer research at MBC gala that raised $150K.

Katrina Cooke has beaten the odds; surviving nearly nine years with metastatic breast cancer. Giving of her time to make things better for others has been her lifeline.

DCI faculty Michaela Dinan, PhD, on the impact of the Oncotype DX test on HR+ breast cancer patients over 65, treatment disparities, & the latest therapies.

Donald McDonnell, PhD, has been recognized for his leadership in estrogen receptor biology by Susan G. Komen with a Brinker Award for Scientific Distinction in Basic Science.
 

Gynecologic oncologist Angeles Alvarez Secord, MD, MHS, weighs in on screening & symptoms in ovarian cancer. September is National Ovarian Cancer Awareness Month.

Komen NCTC hosts its first annual gala to support metastatic breast cancer research; a virtual event with speakers, auctions, and treats on Saturday, October 10, at 7 p.m.

A new approach to training computational models on biological processes provides insights into how and why cancer cells metastasize to certain areas of the vasculature.

Diagnosed with stage 4 ovarian cancer three years ago, Kathy Jennings was thrown a lifeline when she came to Duke Cancer Center.

A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at DCI is part of an effective, two-drug strategy for enlisting the immune system to fight tumors.

Radiation oncologist Joseph Kamel Salama, MD, named to the 2020 class of ASTRO Fellows.

New optical sensing platform can detect genomic cancer biomarkers directly in patient tissues.

Research led by DCI member David Sherwood, PhD, may help pinpoint what might be going wrong in human diseases ranging from kidney disease to invasive cancer.

On-demand viewing of AACR Annual Meeting sessions is now available. Duke presenters included Hema Adhikari, PhD, and Daniel George, MD.

Duke Cancer Institute welcomes a new clinical investigator specializing in bladder cancer to its Genitourinary Oncology program.

In May, a phased-in process of reopening labs began, and by June 15 most labs were functioning at least on a partial basis.

On June 9, DCI and Susan G. Komen Triangle to Coast hosted "Navigating Survivorship,"a live patient forum on breast cancer and survivorship.

Cancer doesn't wait for COVID-19.

The Donald Lab, led by Bruce Donald, PhD, is designing proteins for a historically undruggable protein that’s implicated in difficult-to-treat cancers like pancreatic cancer.

Lyerly, Hartman spinout company Replicate Bioscience and Immunomic Therapeutics form collaboration to combat infectious diseases and cancers.

The Duke Cancer Institute Virtual Grand Rounds Series, came to a successful summer close with its final session on June 19.

Immunology expert Allan Kirk, MD, PhD, discusses what compels the immune system to respond to danger, and how our immune systems change over time.

Funding from the Elsa U. Pardee Foundation will allow investigator to study muscle regeneration and cancer.

Scott Soderling, PhD, has founded a Duke spinout company based on a technology developed in his lab that uses the genome-editing tool CRISPR.

 Yvonne Mowery, MD, PhD, was one of four young physician-scientists nationwide selected to receive the Damon Runyon Clinical Investigator Award.

Radiation oncologist Junzo Chino, MD, served as vice chair of the task force releasing recommendations for radiation therapy in nonmetastatic cervical cancer.

The authors, including corresponding author Madan Kwatra, MD, report that osimertinib inhibits the constitutive activity of EGFRv III tyrosine kinase with high potency.

Duke Cancer Institute will present more than 100 abstracts across multiple cancer types during the ASCO20 Virtual Scientific Program of the 2020 ASCO Annual Meeting.

Duke Cancer Institute's Michael Spiritos, MD, Meenal Kheterpal, MD, Momen Wahidi, MD, MBA, and Mustafa Bashir, MD, awarded 2020 DIHI Innovation Project Grants.

Duke Cancer Institute member and family physician Kevin Oeffinger, MD, has been named a Fellow of the American Society of Clinical Oncology (FASCO). 

Medical oncologist John Strickler, MD, and his patient Tom Vibert, a stage 4 colon cancer survivor, talk about the importance of biomarker testing.

Kyle Strickland, MD, PhD, received a Foundation for Women’s Cancer grant for research on endometrial cancer.

The research team found a signaling pathway within melanoma and other cancers that thwart the functioning of anti-PD-1 checkpoint inhibitors.

Duke University School of Medicine podcast "HeadScratchers" features Kelly Marcom, MD.

Christopher Kelsey, MD, associate professor in the Department of Radiation Oncology and DCI member, was awarded the 2020 Algernon Sydney Sullivan Award.

Nia Mitchell, MD, MPH, will presents: "Developing a Framework for Integrating Take Off Pounds Sensibly (TOPS) into Community Health Centers."

Kris Wood, PhD, and team, are investigating how to turn a tumor’s strength – its drug resistance – into a weakness. This research was published in Nature Genetics.

If mothers, sisters and daughters have a history of breast and ovarian cancers, a man's risk for prostate cancer is also significantly increased.